Currently, there are limited therapeutic options for MELAS syndrome. However, research into enzyme replacement therapy and gene editing technologies like CRISPR holds promise. These approaches aim to correct the underlying genetic defects or supplement the deficient enzymatic activity. Additionally, antioxidants are sometimes used to mitigate oxidative stress, which is often exacerbated by impaired mitochondrial function.
